scispace - formally typeset
A

Antonio Cuneo

Researcher at University of Ferrara

Publications -  354
Citations -  9789

Antonio Cuneo is an academic researcher from University of Ferrara. The author has contributed to research in topics: Chronic lymphocytic leukemia & Leukemia. The author has an hindex of 51, co-authored 320 publications receiving 8567 citations. Previous affiliations of Antonio Cuneo include Katholieke Universiteit Leuven.

Papers
More filters
Journal ArticleDOI

Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.

TL;DR: Chromosomal analysis provides prognostic information about overall survival in addition to that supplied by clinical data in patients with B-cell CLL.
Journal ArticleDOI

Prognostic impact of c-KIT mutations in core binding factor leukemias. an Italian retrospective study

TL;DR: Findings indicate that c-KIT TKD(816) mutation has a negative impact on the outcome of AML with t(8;21), which is associated with a high white blood cell count at diagnosis and a higher incidence of extramedullary leukemia during the course of the disease.
Journal ArticleDOI

P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia.

TL;DR: The results suggest that expression and function of P2X7R may correlate with the severity of B-cell chronic lymphocytic leukemia.
Journal ArticleDOI

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.

Lydia Scarfò, +81 more
- 09 Jul 2020 - 
TL;DR: In CLL, COVID-19 severity increases with age; antileukemic treatment (particularly BTK inhibitors) appears to exert a protective effect; age and comorbidities did not impact on mortality, alluding to a relevant role of CLL and immunodeficiency.